Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
European School of Oncology
May 16, 2024, 11:06 |
Societies
Stephanie Graff: Chairs kick off ESMOBreast24
Paolo Tarantino shared a post by Stephanie Graff on X, adding: . "Impressive continuous growth…
May 15, 2024, 13:59 |
Blog
Stephanie Graff: Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer
Stephanie Graff shared a post on X: “Out now Joint EANM-SNMMI guideline on the role…
May 15, 2024, 12:48 |
Opinion
Paolo Tarantino: Honored to serve as Ambassador for ESMOBreast24!
Paolo Tarantino shared a post by ESMO, on LinkedIn: "Honored to join this outstanding group and…
May 15, 2024, 04:35 |
Blog
Paolo Tarantino: A pleasure to co-host the latest ESMO Open podcast with Giuseppe Curigliano
Paolo Tarantino shared a post by ESMO - European Society for Medical Oncology on LinkedIn, adding:…
May 14, 2024, 05:28 |
Cancer Types
Rhabdomyosarcoma: What patients and caregivers should know about
What is Rhabdomyosarcoma? Rhabdomyosarcoma is a type of soft tissue sarcoma that typically begins in…
May 14, 2024, 03:26 |
Blog
Top 10 Abstracts at ESMO Breast 24 by Paolo Tarantino
Paolo Tarantino made the following post on LinkedIn: "Less than 48h to ESMO Breast 24:…
May 14, 2024, 03:07 |
Blog
Erika Hamilton: Fantastic list for ESMO Breast 24
Erika Hamilton shared a post by Paolo Tarantino on LinkedIn, adding: "Fantastic list for ESMO Breast 24.…
May 13, 2024, 07:12 |
Blog
Paolo Tarantino: DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my friend and mentor of many years Giuseppe Curigliano
Paolo Tarantino shared on X: "DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my…
May 11, 2024, 11:39 |
Blog
Julia Maués: HER2-positive, HER2-low, HER2-shy
Julia Maués, Co-Founder of Grasp Cancer, shared a post by Paolo Tarantino on X and…
May 11, 2024, 11:23 |
Insight
Matt Sagan: Moving from HER2+ to HER2-low to HER2- ultralow
Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by Paolo Tarantino on X,…
22
23
24
25
26
All:
270
Posts:
231 - 240
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
World - first lung cancer vaccine trials launched across 7 countries
Facebook
RSS Feed
X
Linkedin
Youtube